COMPANY · NIPC 980180651

Comercial Rafer

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €5,377,512.90 across 56 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameComercial Rafer
NIPC980180651

None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2012 to 2021. The table below gives the same values.2012: €1,301,51620122013: €884,762.542014: €146,547.2320142015: €148,248.802016: €507,756.4220162017: €677,543.762018: €317,756.7620182019: €133,967.802020: €1,149,017.6720202021: €110,395.92€1,301,516
Contracted value by year
YearContractsContract value
20125€1,301,516
20133€884,762.54
20144€146,547.23
20153€148,248.80
20163€507,756.42
20178€677,543.76
20183€317,756.76
20195€133,967.80
20208€1,149,017.67
202114€110,395.92
Contracted value by place of performance
NameContractsContract value
Lisboa33€5,055,213.90
Porto27€3,914,465.18
Coimbra18€3,780,341.56
Vila Nova de Gaia1€329.40
Largest contracts
SubjectYearContract value
Aquisição de Reagentes para Definição de Alosensibilização HLA em Histocompatibilidade Clínica para o Instituto Português do Sangue e da Transplantação, IP2020€915,601.30
Aquisição de Reagentes para Genotipagem HLA de Baixa Resolução e Definição de Alosensibilização em Histocompatibilidade Clínica para IPST. IP2013€736,042.93
Aquisição de consumiveis para os Laboratórios de Serologia da Transplantação dos CSTL, CSTC e CSTP-Transplantação, do IPST.IP2012€691,748
Locação de equipamento de reagentes para Laboratório de Imunogenética2012€404,940
Aquisição de Reagentes Definição dos Perfis de Alosensibilização2017€307,324

Who they competed with

In 29 contracts with a list of competitors, the company took part and was awarded 6 (21%).

Companies with the most procedures in common
CompanyProcedures in common
VWR internacional - Material de laboratório unipessoal, Lda3
Diagnostica Longwood SL3
NORMAX FABRICA VIDROS CIENTIFICOS, LDA2
PVL-Produtos para Laboratório, Lda2
Alfagene, Novas Tecnologias Ciências da Vida, LDA2
Iberlab & Imunoreage - Soluções para Laboratório, Lda.2
ENZIFARMA, S.A.2
Concessus, S.A.1
LEICA MICROSSISTEMAS,LDA.1
Quilaban1
werfen1
BIO-RAD LABORATORIOS1
BATISTA MARQUES DIAGNOSTICA E REAGENTES1
LABOCONTROLE, LDA.1
BIOPORTUGAL1
Irlandox, Lda1
Sarsted , lda1
CITOMED REPRESENTAÇÕES PRODUTOS MÉDICOS1
LusoPalex - Produtos de Saúde, Unipessoal, Lda.1
EUROIMMUN Portugal1
Fisher Scientific, Lda.1
Labor Spirit, Lda1
Frilabo II, Lda.1
Zmway1
CSP Saúde - Centro Serviços Partilhados, SA1
BECTON DICKINSON PORTUGAL UNIPESSOAL, LDA1
Life Technologies Europe BV1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents30 companies and 30 links. The list below gives the same content as text.Concessus, S.A. (NIPC 500070040)Concessus, S.A.NIPC 500153370 (NIPC 500153370)NIPC 500153370NORMAX FABRICA… (NIPC 500203130)NORMAX FABRICA…LEICA MICROSSI… (NIPC 500301921)LEICA MICROSSI…Quilaban (NIPC 500399670)Quilabanwerfen (NIPC 501086110)werfenBIO-RAD LABORA… (NIPC 501301321)BIO-RAD LABORA…PVL-Produtos p… (NIPC 501411852)PVL-Produtos p…BATISTA MARQUE… (NIPC 501439110)BATISTA MARQUE…ENZIFARMA, S.A. (NIPC 503636975)ENZIFARMA, S.A.NIPC 980180651 (NIPC 980180651)NIPC 980180651+19 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

18 more links

Investigations that mention it

No published investigation mentions this company by NIPC.